XGN

Exagen Inc.

2.13 USD
+0.28 (+15.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Exagen Inc. stock is down -7.39% since 30 days ago. The next earnings date is Mar 18, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 4 March’s closed higher than February.

About Exagen Inc.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases. Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases.